Knoll Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Knoll Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-498,625	Closed	-$461K	–	35
2025 Q3	$461K	Hold	498,625	–	–	0.25%	34
2025 Q2	$626K	Hold	498,625	–	–	0.44%	33
2025 Q1	$539K	Hold	498,625	–	–	0.35%	32
2024 Q4	$1M	Sell	498,625 -53,113	-10%	-$164K	0.65%	24
2024 Q3	$7.19M	Sell	551,738 -1	-0%	-$5	3.33%	8
2024 Q2	$3.26M	Hold	551,739	–	–	2.2%	12
2024 Q1	$3.93M	Hold	551,739	–	–	2.44%	8
2023 Q4	$4.47M	Hold	551,739	–	–	3.7%	6
2023 Q3	$3.4M	Hold	551,739	–	–	3.53%	5
2023 Q2	$4.86M	Buy	551,739 +521,739	+1,739%	+$5.79M	5.89%	4
2023 Q1	$221K	Buy	30,000 +25,000	+500%	+$224K	0.34%	26
2022 Q4	$40.5K	Buy	+5,000	New	+$54.2K	0.09%	20

Knoll Capital Management's HOOK Position: Q4 2025 in Review

Knoll Capital Management sold out of HOOKIPA Pharma (HOOK) in Q4 2025, closing a stake of 498,625 shares — an estimated $461K sold.

Knoll Capital Management first reported a position in HOOK in Q4 2022 and held it in 12 quarters. The position peaked at $7.19M in Q3 2024. 0 funds tracked by Wall St. Rank hold HOOK as of Q4 2025.

Knoll Capital Management reported no remaining HOOKIPA Pharma position as of Q4 2025 after selling out during the quarter.
Knoll Capital Management sold 498,625 HOOKIPA Pharma shares in Q4 2025, an estimated $461K.
Knoll Capital Management first reported a position in HOOKIPA Pharma in Q4 2022 and held it in 12 quarters.
Knoll Capital Management's HOOKIPA Pharma position peaked at $7.19M in Q3 2024.
0 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2025.

Based on Knoll Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.